Xiaofang You

858 citations
32 papers · 619 indexed · h-index 14
Topics
Tracheal and airway disorders (5 papers)Lung Cancer Diagnosis and Treatment (4 papers)Acupuncture Treatment Research Studies (4 papers)
Partner nations
ChinaItalyAustralia

In The Last Decade

Xiaofang You

31 papers receiving 608 citations

Peers

Xiaofang You
Comparison fields: 5 of 100
  • Epidemiology 212
  • Radiology, Nuclear Medicine and Imaging 211
  • Pulmonary and Respiratory Medicine 155
  • Ophthalmology 135
  • Oncology 108
Replace Kun Lv with:
Kun Lv China
Stefania Nannoni Switzerland
Robert F. James United States
Puneet Belani United States
P. González Spain
Mary Qiu United States
Renske G. Wieberdink Netherlands
Yiping Wei China
Mohamed Amine Benadjaoud France
Xiaofang You relative to Kun Lv China Kun Lv's profile →
Citations per field
00.5×
Kun Lv · 1×
Citations per year

Countries citing papers authored by Xiaofang You

Since Specialization
Citations

This map shows the geographic impact of Xiaofang You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang You more than expected).

Fields of papers citing papers by Xiaofang You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang You. The network helps show where Xiaofang You may publish in the future.

Co-authorship network of co-authors of Xiaofang You

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang You. A scholar is included among the top collaborators of Xiaofang You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang You. Xiaofang You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 1
4 15
5 3
6 9
7 6
8 86
9 0
10 32
11 1
12 33
13 16
14 129
15 9
16 57
17 21
18 13
19 1
20 24

About Xiaofang You

Xiaofang You is a scholar working on Complementary and alternative medicine, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 619 indexed citations. Recurring topics across this work include Tracheal and airway disorders (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Acupuncture Treatment Research Studies (4 papers). The work is most often cited by research in Ophthalmology (135 citations), Radiology, Nuclear Medicine and Imaging (211 citations) and Epidemiology (212 citations). Xiaofang You has collaborated with scholars based in China, Italy and Australia. Frequent co-authors include Hui Tan, Haidong Zou, Jianfeng Zhu, Xiaomei Qu, Huijing Shi, Xiangui He, Tao Jiang, Sifei Sun, Lina Lu and Ling Wang. Their work appears in journals such as PLoS ONE, Waste Management and The Annals of Thoracic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026